Recent progress in nanotechnology-based drug carriers for resveratrol delivery

C Li, Z Wang, H Lei, D Zhang - Drug delivery, 2023 - Taylor & Francis
Resveratrol is a polyphenol with diverse pharmacological activities, but its clinical efficacy is
limited due to low solubility/permeability, light-induced isomerization, auto-oxidation, and …

Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease

H Zhang, Y Wang, Y Wang, X Li, S Wang… - European Journal of …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), as the fourth leading cause of death among the elderly
worldwide, has brought enormous challenge to the society. Due to its extremely complex …

Inflammation, lifestyle factors, and the microbiome‐gut‐brain Axis: relevance to depression and antidepressant action

F Donoso, JF Cryan… - Clinical …, 2023 - Wiley Online Library
Depression is considered a major public health concern, where existing pharmacological
treatments are not equally effective across all patients. The pathogenesis of depression …

Insulin resistance and diabetes mellitus in Alzheimer's disease

J Burillo, P Marqués, B Jiménez, C González-Blanco… - Cells, 2021 - mdpi.com
Type 2 diabetes mellitus is a progressive disease that is characterized by the appearance of
insulin resistance. The term insulin resistance is very wide and could affect different proteins …

Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside

F Islam, MH Nafady, MR Islam, S Saha, S Rashid… - Molecular …, 2022 - Springer
Alzheimer's disease (AD) is the most common cause of dementia and cognitive impairment;
yet, there is currently no treatment. A buildup of Aβ, tau protein phosphorylation, oxidative …

The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and …

MS Karvandi, F Sheikhzadeh Hesari… - Frontiers in Cellular …, 2023 - frontiersin.org
Neuronal loss is one of the striking causes of various central nervous system (CNS)
disorders, including major neurodegenerative diseases, such as Alzheimer's disease (AD) …

Sustainable drug discovery of multi-target-directed ligands for Alzheimer's disease

M Rossi, M Freschi… - Journal of medicinal …, 2021 - ACS Publications
The multifactorial nature of Alzheimer's disease (AD) is a reason for the lack of effective
drugs as well as a basis for the development of “multi-target-directed ligands”(MTDLs). As …

A mosquito salivary protein-driven influx of myeloid cells facilitates flavivirus transmission

Z Wang, K Nie, Y Liang, J Niu, X Yu, O Zhang… - The EMBO …, 2024 - embopress.org
Mosquitoes transmit many disease-relevant flaviviruses. Efficient viral transmission to
mammalian hosts requires mosquito salivary factors. However, the specific salivary …

Natural products for the treatment of neurodegenerative diseases

D Cui, Y Chen, B Ye, W Guo, D Wang, J He - Phytomedicine, 2023 - Elsevier
Background Neurodegenerative diseases are among the most common diseases in older
adults worldwide. Alzheimer's disease (AD) and Parkinson's disease (PD) are two of the …

[HTML][HTML] Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants

J Feng, Y Zheng, M Guo, I Ares, M Martínez… - … Pharmaceutica Sinica B, 2023 - Elsevier
In recent years, growing awareness of the role of oxidative stress in brain health has
prompted antioxidants, especially dietary antioxidants, to receive growing attention as …